Process View
The series of events in which a biotic stimulus, one caused or produced by a living organism, is received and converted into a molecular signal.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "detection of biotic stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| B2M | beta-2-microglobulin | 1.000 | ||
| HLA-A | major histocompatibility complex, class I, A | 1.000 | ||
| HLA-C | major histocompatibility complex, class I, C | 1.000 | Human | |
| HLA-B | major histocompatibility complex, class I, B | 1.000 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.985 | Human | |
| HLA-G | major histocompatibility complex, class I, G | 0.975 | Human | |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.939 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.918 | Human | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.892 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.856 | ||
| TLR4 | toll-like receptor 4 | 0.822 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.755 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.627 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.596 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.386 | ||
| TLR1 | toll-like receptor 1 | 0.383 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.360 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.298 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.290 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.289 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.268 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.254 | ||
| CTSS | cathepsin S | 0.232 | ||
| LY96 | lymphocyte antigen 96 | 0.218 | ||
| PYCARD | PYD and CARD domain containing | 0.149 | ||
| PTCH1 | patched 1 | 0.088 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.081 | Human | |
| NPC2 | Niemann-Pick disease, type C2 | 0.077 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.059 | ||
| CD14 | CD14 molecule | 0.057 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.050 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.048 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.043 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.041 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.037 | ||
| TPP1 | tripeptidyl peptidase I | 0.035 | ||
| TAPBP | TAP binding protein (tapasin) | 0.033 | ||
| TLR2 | toll-like receptor 2 | 0.032 | ||
| HCP5 | HLA complex P5 | 0.029 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.026 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.026 | ||
| PGCP | plasma glutamate carboxypeptidase | 0.025 | ||
| VNN2 | vanin 2 | 0.025 | ||
| LY86 | lymphocyte antigen 86 | 0.024 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.023 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.021 | ||
| HFE | hemochromatosis | 0.019 | Human | |
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.019 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.018 | ||
| PYDC2 | pyrin domain containing 2 | 0.018 | ||
| CLEC2B | C-type lectin domain family 2, member B | 0.017 | ||
| FTL | ferritin, light polypeptide | 0.016 | ||
| PSAP | prosaposin | 0.016 | ||
| CST3 | cystatin C | 0.015 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.015 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.014 | ||
| CYTIP | cytohesin 1 interacting protein | 0.014 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.014 | ||
| PTAFR | platelet-activating factor receptor | 0.014 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.013 | ||
| CARD16 | caspase recruitment domain family, member 16 | 0.013 | ||
| FGL2 | fibrinogen-like 2 | 0.013 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.013 | ||
| TRIM38 | tripartite motif containing 38 | 0.012 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.012 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.012 | ||
| GRN | granulin | 0.012 | ||
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.011 | ||
| TLR5 | toll-like receptor 5 | 0.011 | Human | |
| BST1 | bone marrow stromal cell antigen 1 | 0.011 | ||
| BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 0.011 | ||
| EVI2B | ecotropic viral integration site 2B | 0.011 | ||
| C1S | complement component 1, s subcomponent | 0.011 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.010 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.010 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.010 | ||
| CTSO | cathepsin O | 0.010 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.010 | ||
| TLR6 | toll-like receptor 6 | 0.010 |